234 related articles for article (PubMed ID: 16442827)
21. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
[TBL] [Abstract][Full Text] [Related]
22. [Pathological evaluation of soft tissue sarcoma for diagnosis, prognosis and treatment].
Yamaguchi U; Hasegawa T
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1340-5. PubMed ID: 15446553
[TBL] [Abstract][Full Text] [Related]
23. Utilization of fluorescence in situ hybridization in the diagnosis of 230 mesenchymal neoplasms: an institutional experience.
Tanas MR; Rubin BP; Tubbs RR; Billings SD; Downs-Kelly E; Goldblum JR
Arch Pathol Lab Med; 2010 Dec; 134(12):1797-803. PubMed ID: 21128778
[TBL] [Abstract][Full Text] [Related]
24. Correlation of Classic and Molecular Cytogenetic Alterations in Soft-Tissue Sarcomas: Analysis of 46 Tumors With Emphasis on Adipocytic Tumors and Synovial Sarcoma.
Rao UN; Cieply K; Sherer C; Surti U; Gollin SM
Appl Immunohistochem Mol Morphol; 2017 Mar; 25(3):168-177. PubMed ID: 26808135
[TBL] [Abstract][Full Text] [Related]
25. Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET.
Riggi N; Cironi L; Suvà ML; Stamenkovic I
J Pathol; 2007 Sep; 213(1):4-20. PubMed ID: 17691072
[TBL] [Abstract][Full Text] [Related]
26. Analysis of soft tissue sarcomas in 1118 cases.
Fang ZW; Chen J; Teng S; Chen Y; Xue RF
Chin Med J (Engl); 2009 Jan; 122(1):51-3. PubMed ID: 19187617
[TBL] [Abstract][Full Text] [Related]
27. Impact of molecular analysis on the final sarcoma diagnosis: a study on 763 cases collected during a European epidemiological study.
Neuville A; Ranchère-Vince D; Dei Tos AP; Montesco MC; Hostein I; Toffolatti L; Chibon F; Pissaloux D; Alberti L; Decouvelaere AV; Albert S; Rossi CR; Blay JY; Coindre JM
Am J Surg Pathol; 2013 Aug; 37(8):1259-68. PubMed ID: 23774173
[TBL] [Abstract][Full Text] [Related]
28. Molecular classification of soft tissue sarcomas and its clinical applications.
Jain S; Xu R; Prieto VG; Lee P
Int J Clin Exp Pathol; 2010 Apr; 3(4):416-28. PubMed ID: 20490332
[TBL] [Abstract][Full Text] [Related]
29. [Molecular genetics in the diagnosis of bone and soft tissue tumours].
Bjerkehagen B; Myklebost O
Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3286-9. PubMed ID: 16327856
[TBL] [Abstract][Full Text] [Related]
30. Unusual Signal Patterns of Break-apart FISH Probes Used in the Diagnosis of Soft Tissue Sarcomas.
Papp G; Mihály D; Sápi Z
Pathol Oncol Res; 2017 Oct; 23(4):863-871. PubMed ID: 28108880
[TBL] [Abstract][Full Text] [Related]
31. Risk assignment in pediatric soft-tissue sarcomas: an evolving molecular classification.
Qualman SJ; Morotti RA
Curr Oncol Rep; 2002 Mar; 4(2):123-30. PubMed ID: 11822984
[TBL] [Abstract][Full Text] [Related]
32. Adult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosis.
Stock N; Chibon F; Binh MB; Terrier P; Michels JJ; Valo I; Robin YM; Guillou L; Ranchère-Vince D; Decouvelaere AV; Collin F; Birtwisle-Peyrottes I; Gregoire F; Aurias A; Coindre JM
Am J Surg Pathol; 2009 Dec; 33(12):1850-9. PubMed ID: 19898221
[TBL] [Abstract][Full Text] [Related]
33. Claudin-1 is expressed in perineurioma-like low-grade fibromyxoid sarcoma.
Thway K; Fisher C; Debiec-Rychter M; Calonje E
Hum Pathol; 2009 Nov; 40(11):1586-90. PubMed ID: 19540561
[TBL] [Abstract][Full Text] [Related]
34. [Molecular genetic alterations and their prognostic values in soft tissue sarcomas].
Oda Y; Tsuneyoshi M
Fukuoka Igaku Zasshi; 2007 Jul; 98(7):287-94. PubMed ID: 17710893
[No Abstract] [Full Text] [Related]
35. [Targeted treatment of rare connective tissue tumors and sarcomas].
Cassier P; Pissaloux D; Alberti L; Ray-Coquard I; Blay JY
Bull Cancer; 2010 Jun; 97(6):693-700. PubMed ID: 20497911
[TBL] [Abstract][Full Text] [Related]
36. [Molecular biology diagnosis of tumors of the musculoskeletal system].
Bovée JV; Hogendoorn PC
Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2557-62. PubMed ID: 9555157
[TBL] [Abstract][Full Text] [Related]
37. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
[TBL] [Abstract][Full Text] [Related]
38. Molecular profiling in the diagnosis and treatment of high grade sarcomas.
Antonescu CR
Ultrastruct Pathol; 2008; 32(2):37-42. PubMed ID: 18446666
[TBL] [Abstract][Full Text] [Related]
39. Sporadic amplification of the c-fms proto-oncogene in human musculoskeletal sarcomas.
Castresana JS; Barrios C; Ruiz J; Gómez L; Kreicbergs A
Anticancer Res; 1993; 13(3):807-10. PubMed ID: 8317916
[TBL] [Abstract][Full Text] [Related]
40. Clinical relevance of molecular genetics to paediatric sarcomas.
Slater O; Shipley J
J Clin Pathol; 2007 Nov; 60(11):1187-94. PubMed ID: 17468291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
